COMP <GO>
LFVN vs UNH // GROSS PROFIT MARGIN
Lifevantage Corporation (Delaware) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: LFVN 9
— UNH 4
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $5.76 (-1.87%) • MKT CAP: $73.9M
gross-margins
80.40%
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
gross-margins
88.31%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LFVN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LFVN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 80.40% | 88.31% | -7.91 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.20% | 12.38% | +16.82 | LFVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.5x | 15.3x | -9.77 | LFVN | /valuation <GO> |
| Free Cash Flow Yield | 14.22% | 6.25% | +7.97 | LFVN | /fcf-yield <GO> |
| Operating Margin | 5.30% | 5.32% | -0.02 | UNH | /operating-margins <GO> |
| Net Profit Margin | 4.30% | 3.53% | +0.77 | LFVN | /net-margins <GO> |
| Revenue Growth (YoY) | 14.20% | 3.33% | +10.87 | LFVN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.80% | 2.29% | +0.51 | LFVN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.98 | 3.09 | +0.89 | LFVN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | LFVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.2 | 55.1 | -11.90 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.3x | 17.7x | -11.44 | LFVN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $73.9M | $359.43B | -$359.36B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LFVN REV | UNH REV | LFVN GROSS % | UNH GROSS % | LFVN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $228.5M | $447.57B | 80.4% | 88.7% | $10.5M | $16.07B |
| FY 2024 | $200.2M | $400.28B | 79.3% | 88.3% | $10.0M | $20.70B |
| FY 2023 | $213.4M | $371.62B | — | 89.6% | $6.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LFVN // BETA —
UNH // BETA 0.33